New insights into the pathophysiology and treatment of nephrolithiasis: New research venues

Journal of Bone and Mineral Research

Volumn 12, Issue 4, 1997, Pages 522-533

  Coe, Fredric L ^a   Parks, Joan H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; CITRIC ACID; URIC ACID;

CRYSTALLIZATION; HUMAN; NEPHROLITHIASIS; PATHOPHYSIOLOGY; PRECIPITATION; REVIEW; STONE FORMATION; URINE PH; URINE VOLUME;

ANIMALS; FEMALE; HUMANS; KIDNEY CALCULI; MALE;

EID: 0030956348     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.4.522     Document Type: Review

References (112)

1. Tiselius H 1996 Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven Publishers, Philadelphia, PA, U.S.A., p. 33.
2. Herring LC 1962 Observations on the analysis of ten thousand urinary calculus. J Urol 88:545-555.
3. Francis MD, Webb NC 1971 Hydroxyapatite formation from a hydrated calcium monohydrate phosphate precursor. Calif Tissue Res 6:335-342.
4. Coe FL, Parks JH, Asplin JR 1992 The pathogenesis and treatment of kidney stones - Medical progress. New Engl J Med 327:1141-1152.
5. Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) 1996 Kidney Stones: Medical and Surgical Management. Lippincott-Raven Publishers, Philadelphia, PA, U.S.A., p. 1.
6. Caudarella R, Rizzoli E, Pironi L, Malavolta N, Martelli G, Poggioli G, Gozzetti G, Miglioli M 1993 Renal stone formation in patients with inflammatory bowel disease. Scan Microsc 7:371-379, discussion 379-380.
7. Obialo CI, Clayman RV, Matts JP, Fitch LL, Buchwald H, Gillis M, Hruska KA 1991 Pathogenesis of nephrolithiasis post-partial ileal bypass surgery: Case-control study. The POSCH Group. Kidney Int 39:1249-1254.
8. Coe FL, Parks JH 1988 Hyperoxaluric states. In: Nephrolithiasis: Pathogenesis and Treatment. Year Book Medical Publishers, Chicago, IL, U.S.A., p. 172.
9. Yu TF, Gutman AB 1967 Uric acid nephrolithiasis in gout: Predisposing factors. Ann Intern Med 67:1133-1148.
10. Gutman AB, Yu TF 1968 Uric acid nephrollithiasis. Am J Med 45:756-759.
11. Buckalew VM Jr 1992 Calcium nephrolithiasis and renal tubular acidosis. In: Coe FL, Favus MJ (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, NY, U.S.A., p. 729.
12. Sakhaee K, Alpern R, Jacobson HR, Pak CYC 1991 Contrasting effects of various potassium salts on renal citrate excretion. J Clin Endocrinol Metab 72:396-400.
13. Breslau NA, Mcguire JL, Zerwekh JE, Pak CYC 1982 The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 55:369-373.
14. Kok DJ, Iestra JA, Doorenbos CJ, Papapoulos SE 1990 The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men. J Clin Endocrinol Metab 71:861-867.
15. Caruana RJ, Buckalew VM 1988 The syndrome of distal (type 1) renal tubular acidosis: Clinical and laboratory findings in 58 cases. Medicine (Baltimore) 67:84-99.
16. Parks JH, Coward M, Coe FL 1996 Coorespondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int (in press).
17. Asplin JR, Mandel NS, Coe FL 1996 Evidence for calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604-F613.
18. Meyer JL, Bergert JH, Smith LH 1975 Epitaxial relationships in urolithiasis: The calcium oxalate monohydrate-hydroxyapatite system. Clin Sci Mol Med 49:369-374.
19. Coe FL, Parks JH 1988 Primary hyperparathyroidism. In: Nephrolithiasis: Pathogenesis and Treatment. Year Book Medical Publishers, Chicago, IL, U.S.A., p. 59.
20. Weiner IM 1993 Diuretics and other agents employed in the mobilization of edema fluid. In: Goodman and oilman's: The Pharmacological Basis of Therapeutics. Gilman AG, Rall TW, Nies AS, Taylor P (eds.) Mc-Graw Hill, Inc., New York, NY, U.S.A., p. 713.
21. Favus MJ 1992 Intestinal absorption of calcium, magnesium, and phosphorus. In: Coe FL, Favus MJ, (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, NY, U.S.A., p. 57.
22. Bilezikian JP 1996 Nephrolithiasis in primary hyperparathyroidiam. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven, Philadelphia, PA, U.S.A., p. 787.
23. Parks J, Coe F, Favus M 1980 Hyperparathyroidism in nephrolithiasis. Arch Intern Med 140:1479-1481.
24. Ladenson JH 1991 Calcium determination in primary hyperparathyroidism. J Bone Miner Res 6:(Suppl 2):S33-S51.
25. College of American Pathologists, CAP SURVEYS, Chemistry Survey 1996 Sets, C3,C4,C5,C6,C7-1. College of American Pathologists Participant Surveys: 1-82 (abstract).
26. Kaplan EL, Tanaka R, Younes N 1996 Primary hyperparathyroidism. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven Publishers, Philadelphia, PA, U.S.A., p. 803.
27. Silver J, Naveh-Many T 1996 Parathyroid hormone synthesis, secretion and action. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven, Philadelphia, PA, U.S.A., p. 175.
28. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL 1986 Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 77:1888-1896.
29. Coe FL, Favus MJ 1986 Disorders of stone formation. In: Brenner BM, Rector FC Jr. (eds.) The Kidney. Saunders, Philadelphia, PA, U.S.A., p. 1403.
30. Lemann JJ 1992 Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Coe FL, Favus MJ (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, NY, U.S.A., p. 685.
31. Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM 1982 Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72:25-32.
32. Lawoyin S, Sismilich S, Browne R, Pak CYC 1979 Bone mineral content in patients with calcium urolithiasis. Metabolism 28:1250-1254.
33. Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG 1980 Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50:654-658.
34. Barkin J, Wilson DR, Manuel MA, Bayley A, Murray T, Harrison J 1985 Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 11:19-24.
35. Bataille P, Achard JM, Fournier A, Boudailliez B, Westeel PF, El Esper N, Bergot C, Jans I, Lalau JD, Petit J, Henon G, Jeantet JAL, Bouillon R, Sebert JL 1991 Diet, Vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39:1193-1205.
36. Pietschmann F, Breslau NA, Pak CY 1992 Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 12:1383-1388.
37. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY 1992 Impaired bone formation in male idiopathic osteoporosis: Further reduction in the presence of concomitant hypercalciuria. Osteoporosis Int 2:128-134.
38. Robertson WG, Morgan DB 1972 The distribution of urinary calcium excretions in normal persons and stone-formers. Clinica Chimica Acta 37:503-508.
39. Finlayson B 1977 Calcium stones: Some physical and clinical aspects. In David DS (ed.) Calcium Metabolism in Renal Failure and Nephrolithiasis. John Wiley & Sons, New York, NY, U.S.A., p. 337.
40. Lemann JJ 1996 Calcium and phosphate metabolism: An overviewin health and in calcium stone formers. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven, Philadelphia, PA, U.S.A., p. 259.
41. Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE 1984 Evidence for disordered control of 1,25 dihydroxyvitamin D production in absorptive hypercalciuria. New Engl J Med 311:73-80.
42. Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC 1977 The role of 1 alpha 25 dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59: 756-760.
43. Shen FH, Baylink DJ, Nielsen RL, Sherrard DJ, Ivey JL, Haussler MR 1977 Increased serum 1,25-dihydroxyvitamin D in Idiopathic Hypercalciuria. J Lab Clin Med 90:955-962.
44. 2 vitamin D levels in humans: Studies in healthy subjects in calcium stone formers, and in patients with primary hyper-parathyroidism. J Clin Endocrinol Metab 45:299-306.
45. Coe FL, Parks JH, Bushinsky DA, Langman CB, Favus MJ 1988 Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 33:1140-1146.
46. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL 1995 Stone formation in genetic hypercalciuric rats. Kidney Int 48:1705-1713.
47. Bushinsky DA, Kim H, Sessler NE, Nakagawa YN, Coe FL 1994 Increased urine saturation and calcium kidney content in genetic hypercalciuric rats. Kidney Int 45:58-65.
48. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ 1993 Increased intestinal vitamin D receptor in genetic hypercalciuric rats: A cause of intestinal calcium hyperabsorption. J Clin Invest 91:661-667.
49. Sriussadaporn S, Wong M, Pike JW, Favus MJ 1995 Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat. J Bone Miner Res 10:271-288.
50. Zerwekh JE, Hughes MR, Reed BY, Breslau NA, Heller HJ, Lemke M, Nasonkin I, Pak CY 1995 Evidence for normal vitamin D receptor messenger rihonucleic acid and genotype in absorptive hypercalciuria. J Clin Med Metab 80:2960-2965.
51. Ettinger B, Citron JT, Livermore B, Dolman LI 1988 Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139:679-684.
52. Laerum E, Larsen S 1984 Thiazide prophylaxis of urolithiasis: A double-blind study in general practice. Acta Med Scand 215:383-389.
53. Aubin R, Menard P, Lajeunesse D 1996 Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int 50:1476-1482.
54. Parks JH, Coe FL 1986 A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 30:85-90.
55. Meyer JL, Smith LH 1975 Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 13:36-39.
56. Parks JH, Ruml LA, Pak CYC 1996 Hypocitraturia. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven, Philadelphia, PA, U.S.A., p. 905.
57. Sakhaee K, Williams RH, Oh MS, Padalino P, Adams-Huet B, Whitson P, Pak CY 1993 Alkali absorption and citrate excretion in calcium nephrolithiasis. J Bone Miner Res 8:789-794.
58. Hamm LL, Alpern RJ 1996 Regulation of acid-base balance, citrate, and urine pH. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven, Philadelphia, PA, U.S.A., p. 289.
59. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC 1993 Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150: 1761-1764.
60. Brinkley LJ, Gregory J, Pak CYC 1990 A further study of oxalate bioavailability in foods. J Urol 144:94-96.
61. Hayashi Y, Kaplan RA, Pak CYC 1975 Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine. Metabolism 24(11):1273-1278.
62. Jaeger P, Portmann L, Jacquet A, Burckhardt P 1985 Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers. Am J Nephrol 5:40-44.
63. Kathpalia SC, Favus MJ, Coe FL 1984 Evidence for size and charge permselectivity of rat ascending colon: Effects of ricinoleate and bile salts on oxalic acid and neutral sugar transport. J Clin Invest 74:805-811.
64. Smith LH 1992 Hyperoxaluric states. In: Coe FL, Favus MJ (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, NY, U.S.A., p. 707.
65. Andersson H, Jagenburg R 1974 Fat-reduced diet in the treatment of hyperoxaluria in patients with ileopathy. Gut 15:360-366.
66. Danpure CJ, Smith LH 1996 The primary hyperoxalurias. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven, Philadelphia, PA, U.S.A., p. 859.
67. Yendt ER, Cohanim M 1985 Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria. New Engl J Med 312:953-957.
68. Van Acker KJ, Eyskens FJ, Espeel MF, Wanders RJA, Dekker C, Kerckaert IO, Roels F 1996 Hyperoxaluria with hyperglycoluria not due to alanine: Glyoxylate aminotransferase defect: A novel ltype of primary hyperoxaluria. Kidney Int 50:1747-1752.
69. Coe FL, Moran E, Kavalich AG 1976 The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis 29:793-800.
70. Coe FL, Raisen L 1993 Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet 1:129-131.
71. Ettinger B, Tang A, Citron JT, Livermore B, Williams T 1986 Randomized trial of allopurinol in the prevention of calcium oxalate calculi. New Engl J Med 315:1386-1389.
72. Finlayson B, Burns J, Smith A, Du Bois L 1979 Effect of oxipurinol and allopurinol riboside on whewellite crystallization: In vitro and in vivo observations. Invest Urol 17:227-229.
73. Coe FL, Lawton RL, Goldstein RB, Tembe V 1975 Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med 149:926-929.
74. Pak CY, Arnold LH 1975 Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 149:930-932.
75. Pak CYC, Holt K, Zerwekh JE 1979 Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation. Invest Urol 17:138-140.
76. Ryall RL, Hibberd CM, Marshall VR 1986 The effect of crystalline monosodium urate on the crystallisation of calcium oxalate in whole human urine. Urol Res 14:63-65.
77. Bisaz S, Felix R, Neuman WF, Fleisch H 1978 Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Miner Electrolyte Metab 1:74-83.
78. Dent CE, Sutor DJ 1971 Presence or absence of inhibitor of calcium-oxalate crystal growth in urine of normals and of stone-formers. Lancet 1:776-778.
79. Rose MB 1975 The inhibitory effect of urine on calcium oxalate precipitation. Invest Urol 12:428-433.
80. Lieske JC, Coe FL 1996 Urinary inhibitors and renal stone formation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney Stones: Medical and Surgical Management. Lippincott-Raven Publishers, Philadelphia, PA, U.S.A., p. 65.
81. Coe FL, Parks JH, Nakagawa Y 1992 Inhibitors and promoters of calcium oxalate crystallization: Their relationship to the pathogenesis and treatment of nephrolithiasis. In: Coe FL, Favus MJ (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, NY, U.S.A., p. 757.
82. Hess B, Nakagawa Y, Coe FL 1989 Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99-F106.
83. Asplin J, Deganello S, Nakagawa YN, Coe FL 1991 Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol 261:F824-F830.
84. Hess B, Nakagawa Y, Parks JH, Coe FL 1991 Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 260:F569-F578.
85. Porile JL, Asplin JR, Parks JH, Nakagawa Y, Coe FL 1996 Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol 7:602-607.
86. Hoyer JR, Otvos L, Urge L1995 Osteopontin in urinary stone formation. Ann New York Acad Sci 760:257-265.
87. Worcester EM, Beshensky AM 1996 Osteopontin inhibits nucleation of calcium oxalate crystals. Ann New York Acad Sci 375-377.
88. Asplin JR, Hoyer JR, Gillespie C, Coe FL 1995 Uropontin (UP) inhibits aggregation of calcium oxalate monohydrate (COM) crystals. J Am Soc Nephrol 6:941 (abstract).
89. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL 1992 The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7:1029-1036.
90. Goldberg HA, Hunter GK 1995 The inhibitory activity of osteopontin on hydroxyapatite formation in vitro. Ann New York Acad Sci 760:305-308.
91. Nakagawa Y, Margolis HC, Yokoyama S, Kezdy FJ, Kaiser ET, Coe FL 1981 Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem 256:3936-3944.
92. Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe FL 1983 Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:12594-12600.
93. Nakagawa Y, Ahmed M, Hall SL, Deganello S, Coe FL 1987 Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth: Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxy-glutamic acid. J Clin Invest 79:1782-1787.
94. Nakagawa Y, Otsuki T, Coe FL 1989 Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer. FEES Lett 250:187-190.
95. Nakagawa Y, Abram V, Parks JH, Lau HS, Kawooya JK, Coe FL 1985 Urine glycoprotein crystal growth inhibitors: Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest 76:1455-1462.
96. Stapleton AMF, Ryall RL 1995 Blood coagulation proteins and urolithiasis are linked: Crystal matrix protein is the F1 activation peptide of human prothrombin. Br J Urol 75:712-719.
97. Doyle IR, Marshall VR, Dawson CJ, Ryall RL 1995 Calcium oxalate crystal matrix extract: The most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro. Urol Res 23:53-62.
98. Atmani F, Khan SR 1995 Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine. Urol Res 23:95-101.
99. Kok DJ, Papapoulos SE, Blomen LJ, Bijvoet OL 1988 Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int 34:346-350.
100. Emmerson BT, Cross M, Osborne JM, Axelson RA 1990 Reaction of MDCK cells to crystals of monosodium urate monohydrate and uric acid. Kidney Int 37:36-43.
101. Emmerson BT, Cross M, Osborne JM, Axelsen RA 1991 Ultrastructural studies of the reaction of urate crystals with a cultured renal tubular cell line. Nephron 59:403-408.
102. Riese RJ, Kleinman JG, Wiessner JH, Mandel OS, Mandel NS 1990 Uric acid crystal binding to renal inner medullary collecting duct cells in primary culture. J Am Soc Nephrol 1:187-192.
103. Riese RJ, Mandel NS, Wiessner JH, Mandel GS, Becker CG, Kleinman JG 1992 Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am J Physiol 262:F177-F184.
104. Lieske JC, Walsh-Reitz MM, Toback FG 1992 Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262:F622-F630.
105. Lieske JC, Toback FG 1993 Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. Am J Physiol 264:F800-F807.
106. Lieske JC, Swift H, Martin T, Patterson B, Toback FG 1994 Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Cell Biol 91:6987-6991.
107. Hammes MS, Lieske JC, Pawar S, Spargo BH, Toback FG 1995 Calcium oxalate monohydrate crystals stimulate gene expression in kidney epithelial cells. Kidney Int 48:501-519.
108. Lieske JC, Toback FG 1996 Interaction of urinary crystals with renal epithelial cells in the pathogenesis of nephrolithiasis. In: Bushinksy DA (ed.) Kidney Stones. W.B. Saunders Company, Philadelphia, PA, U.S.A., p. 458.
109. Lieske JC, Leonard R, Toback FG 1995 Adhesion of calcium oxalate monospecific crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 37:F604-F612.
110. Lieske JC, Leonard R, Swift H, Toback FG 1996 Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 39:F192-F199.
111. Lieske JC, Toback FG, Deganello S 1996 Face-selective adhesion of calcium oxalate dihydrate crystals to renal epithelial cells. Calcif Tissue Int 58:195-200.
112. Scurr DS, Latif AB, Sergeant V, Robertson WG 1983 Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine. Proc Eur Dial Transplant Assoc 20:440-444.